<DOC>
	<DOCNO>NCT01135797</DOCNO>
	<brief_summary>The objective study collect retrospectively long term safety data patient participate previous phase I-II trial conduct compound .</brief_summary>
	<brief_title>Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Inclusion criterion : Patient randomize , treat alive end phase III study participation , irrespective treatment group , Who sign TALISMAN survey inform consent ( deceased patient , informed consent sign legal representative/family member per national regulation except country Ethics Committee approval require retrospective data collection ) . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>